NURS FPX 6021 Assessment 3 Quality Improvement Presentation Poster

Abstract 

It addresses quality improvement action, the built-in check-act (PDCA) cycle in the scheme, and complex biopsychosocial complications that reduce diabetes and kidney failure operations as a rallying point with Mrs. Smith’s case. The design aims to optimize patient issues through a cooperative approach involving nonstop glucose monitoring (CGM) preparation, comprehensive education, and fiscal aid strategies.

The efficiency of the intervention is improved by integrating explanatory collaboration and by incorporating an endocrinologist, children’s producers, dietists, and social workers. Benefits are expected in terms of increase in design, better care quality, and streamlined health processes, contributing to wider population health progress. The purpose of this action is to drive continuous progress in patient care and general distribution of the health care system through nonstop evaluation and adaptation.

Quality Improvement Methods

To promote nonstop growth in dealing with diabetes and kidney failure, especially for cases such as Mrs. Smith, we propose exercising the PDCA cycle. This system involves four crucial ways: planning the intervention, enforcing the plan, checking the results, and acting on what’s learned to upgrade the process. In Mrs. Smith’s case, PDCA can be applied to cover and acclimate her blood glucose situations and renal function. For example, the original plan may involve introducing CGM and diuretics (Yi et al., 2023).

The “do” phase will use these interventions, while the “check” phase involves regular monitoring of blood sugar and renal function tests. The “act” phase would use the gathered data to tweak the intervention, ensuring nonstop enhancement. This cyclical approach ensures that adaptations can be made grounded on real-time data, thereby addressing her care’s physiological (natural) and behavioral (psychosocial) aspects. The PDCA cycle promotes a structured yet flexible framework that promotes the nonstop growth that can continuously unite (Yi et al., 2023).

Limitations of PDCA

Despite its strength, the PDCA cycle presents several challenges. One significant limitation is the eventuality of resistance to change, particularly from cases who may find new technologies like CGM bothersome or clumsy. To alleviate this, comprehensive education and support systems need to be established. Cases should be completely educated about the benefits and use of CGM, and support from healthcare professionals should be readily available to address any enterprises (Sugandh et al., 2023). Furthermore, fiscal walls may hamper the harmonious perpetration of interventions, especially for cases like Mrs. Smith, who face profitable constraints.

Connecting cases to fiscal backing programs can help overcome this hedge (Du et al., 2022). Similarly, a multidisciplinary approach is required to handle biopsychosocial ideas to manage the PDCA cycle, to address all aspects of the case status, and to integrate input from endocrinologists, nephrologists, dietitians, and socioeconomists.This collaboration ensures that the intervention is general and patient-centered.The PDCA cycle can effectively smooth the nonstop quality growth in dealing with complex conditions such as diabetes and kidney failure (Yu et al., 2022) by estimating these challenges and developing continuous strategies to address them.

Evidence-Supported QI Methods

Substantiation supports the effectiveness of the PDCA cycle in managing diabetes and renal failure in cases like Mrs. Smith’s. CGM has been shown to significantly ameliorate glycemic control by furnishing real-time feedback, enabling timely interventions and adaptations to insulin remedy (Martens et al., 2021). Studies demonstrate that CGM druggies witness smaller occurrences of hypoglycemia and better overall glucose operation, which directly supports the “check” and “act” phases of the PDCA cycle.

Likewise, the use of diuretics to manage renal function is backed by guidelines from the American Diabetes Association (ADA), which recommends diuretics for cases with edema and early-stage renal damage to help further deterioration (Afify et al., 2023). This substantiation reinforces the planning and perpetration stages of the PDCA cycle, ensuring that the interventions are both substantiation-grounded and practical.

The most precious substantiation for our design includes the ADA guidelines and the exploration by Martens et al. (2021), as these sources give robust data supporting the integration of CGM and diuretics into the care plan. This substantiation informs the specific QI approach by validating the chosen interventions and ensuring they are aligned with stylish practices for managing diabetes and renal failure, thereby enhancing patient issues like Mrs. Smith’s.

Identify Knowledge Gap 

While substantiation supports the effectiveness of CGM and diuretics, there may be gaps in understanding how these interventions translate into long-term issues for cases like Mrs. Smith. Also, the optimal frequency and duration of CGM operation in managing blood glucose situations still need to be clarified in specific surroundings. Further exploration could explore the impact of socioeconomic factors on drug adherence and its commerce with fiscal backing programs in perfecting health issues for diabetic cases (Kvarnström et al., 2021).

Change Strategy Foundation 

The design is anchored in successful change strategies similar to CGM, fiscal backing for drug adherence, diuretics, and comprehensive education (Kvarnström et al., 2021). These strategies are based on evidence-based practices and guidelines from reputable sources such as the ADA and NANDA (ADA, 2022; NANDA, 2020). Successful perpetration of CGM and drug-backing programs has been demonstrated in analogous QI systems, showcasing their effectiveness in perfecting patient issues.

For example, CGM helps maintain blood glucose situations within the target range, reducing harpoons from 200-350 mg/dL to 80-130 mg/dL fasting and lower than 180 mg/dL postprandial (Lin et al., 2021). These strategies are applicable for this QI design, as they address specific clinical requirements similar to controlling blood glucose situations, managing renal function, and increasing drug adherence in cases like Mrs. Smith, increasing a comprehensive and substantiation-grounded approach to quality enhancement (Lin et al., 2021).

Potential Challenges and Solutions 

Enforcing CGM and fiscal backing programs faces challenges similar to original costs and patient acceptance. To solve this, the case and health professionals will accept extensive workouts and continuous support. Uniting with fiscal relief associations and social associations can help reduce the tax walls. Resistance to change and adherence issues arise, necessitating acclimatized educational interventions and close monitoring of patient progress. Regular feedback and quality enhancement assessments will help identify and address arising challenges throughout the perpetration process (Lin et al., 2021).

Effectiveness of Interprofessional Teamwork 

The interprofessional platoon for this QI design will include endocrinologists, nurses, dietitians, social workers, and nephrologists. The collaboration between these different places ensures a comprehensive approach to meet the versatile needs of issues such as Mrs. Smith, which presents complex biopsychical ideas. By pooling their moxie, platoon members can contribute technical knowledge and chops to develop acclimatized interventions for diabetes operation and give holistic care to renal failure cases like Mrs. Smith. This cooperative approach enhances the design’s quality and effectiveness and promotes a participating understanding of case requirements and pretensions, leading to further case-centered care (Nurchis et al., 2022).

Also, interprofessional cooperation streamlines communication and collaboration among platoon members, reducing duplication of efforts and enhancing design effectiveness. By using each platoon member’s strengths and coffers, the design can achieve its objectives more fleetly and effectively, eventually perfecting patient issues and satisfaction. Hypotheticals for the interprofessional cooperation approach include the vacuity and amenability of all platoon members to unite effectively. Also, it assumes acceptable coffers and support for interprofessional communication and collaboration throughout the design. Eventually, it presupposes that each platoon member possesses the necessary chops and moxie to contribute effectively to the diabetes operation design’s pretensions for cases like Mrs. Smith (Ernawati et al., 2021).

Overall project benefits 

The design benefits include better patient issues through optimized operation of diabetes and renal failure, leading to enhanced quality of life for individuals like Mrs. Smith. Also, the design fosters a culture of nonstop enhancement within the healthcare setting, promoting better patient safety and equity in care delivery. The design aims to reduce healthcare differences and enhance overall population health by addressing biopsychosocial considerations exhaustively. Also, the design’s emphasis on interprofessional collaboration fosters a more cohesive healthcare platoon, leading to lesser job satisfaction and professional development among staff (Ernawati et al., 2021). Eventually, these collaborative advancements contribute to a more effective healthcare system, abetting cases like Mrs. Smith’s and healthcare providers.Looking for guidance? Read our in-depth NURS FPX 6021 Assessment 3 Quality Improvement in Hypertension & COPD sample to ace your coursework with confidence.

NURS FPX 6021 Assessment 3 Quality Improvement Presentation Poster

Kvarnström, K., Westerholm, A., Airaksinen, M., and Liira, H. (2021). Factors that contribute to the observance of the drug in patients with chronic conditions: a scoping review of qualitative research. Pharmaceutics, 13 (7). https://doi.org/10.3390/pharmaceutics13071100 

Lynn, R., Brown, F., James, S., Jones, J., and Ekmani, E. (2021). Constant glucose monitoring: Review of evidence in types 1 and 2 diabetes mellitus. Diabetic medicine, 38 (5). https://doi.org/10.1111/dme.14528 

Martens, T., Bake, R. W., Bailey, R., Ruid, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Timikas, A., Baa, S. T., Orozco, I., Bigs, W., and Lucas, K. (2021). The effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin. Jama, 325 (22). https://doi.org/10.1001/jama.2021.7444 

NANDA. (2020, October 6). NANDA International Nursing Diagnoses, Inc. NANDA. https://nanda.org/publications-resources/publications/nanda-international-nursing-diagnoses/ 

NURS FPX 6021 Assessment 3 Quality Improvement Presentation Poster

Narchis, M. C., Sesa, G., Paskuchi, D., Sasano, M., Lombi, L., and Demiani, G. (2022). Interaction in primary care and diabetes treatment: a systematic review and meta-analysis of patient-reported results. Personal Medical Journal, 12 (4). https://doi.org/10.3390/jpm12040643 

Scent, F. N. U., Chandio, M., Rava, F. N. U., Kumar, L., Karishma, F. N. U., Khuwaja, S., Memon, U. A. A. Kumar, L., Karishma, F. N. U., Khuwaja, S., Memon, U. A. Progress in handling diabetes mellitus: Focus on personal medicine. Cureus, 15 (8), 1-13. https://doi.org/10.7759/cureus.43697 

Yi, Z., Uni, G. A. O., Sheyu, L. I., Nanwei, T., Min, C., Dajiang, L. I., Yan, J., Weyi, Z., & Xiangjun, C. (2023). Perform active blood sugar management during hospitalization based on the PDCA cycle: a practical study. Chinese General Practice, 26 (15). https://doi.org/10.12114/j.issn.1007-9572.2022.0821